Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Sirona Biochem Corp V.SBM

Alternate Symbol(s):  SRBCF

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to... see more

TSXV:SBM - Post Discussion

Sirona Biochem Corp > Upfront Fee Material Information?
View:
Post by sakinny3 on Jul 06, 2022 3:52pm

Upfront Fee Material Information?

If the up front fee is a significant number then surely that is material information that should be required to be announced?
Comment by jimmyhorizon on Jul 06, 2022 9:08pm
  Good question. Can anyone answer it?
Comment by biorun on Jul 06, 2022 9:16pm
Sec disclosure requirements people. it will show up at some point 
Comment by jimmyhorizon on Jul 07, 2022 12:36am
  And here is the question again. Is the receipt of a significant upfront payment subject to disclosure? what does some point mean? Does anyone know?
Comment by biorun on Jul 07, 2022 7:40am
yes, many of us know the "at some point" because we use google and look at the quarterly dates required for disclosure and then work from there.
Comment by jimmyhorizon on Jul 07, 2022 8:26am
thanks bio for getting back to me. i wasn't asking about whether a significant upront payment (let's take the 5-20 million from prc partners) would be disclosed in the quarterly numbers, but whether the RECEIPT of such a payment would be a disclosable event. " 2. Disclosures of Material Nonpublic Information The final regulation, like the proposal, applies to disclosures of ...more  
Comment by biorun on Jul 07, 2022 10:11am
yes, they are required to report all money coming into the coffers as you indicate, but abbvie also has to report a 10k in august where they "may" also be required to disclose certain details. we will see what that brings.  if that does surface and it is in fact more than lcfsa insists, then expect an immediate revaluation within the hour. right now we are trading with near ...more  
Comment by jimmyhorizon on Jul 07, 2022 10:20am
  thank you.  To be clear. If they had received, let's say, 10m upfront in their account last week, then they would only have to disclose this in the next quarterly figures? is that correct?
Comment by biorun on Jul 07, 2022 10:26am
yes, at a minimum for Canada as I understand. if there are future milestone payments, those may not as they are forward looking and conditional. at year end, most of details may also have to be tabled as we saw was forced out with R&F disclosure. it all comes out in the end. look at the details of the wanbang sglt2- that would be the style of eventual reporting that we should certainly expect ...more  
Comment by forhandlaren on Jul 07, 2022 10:47am
Interesting remark about the upcoming Abbvie 10K report. Any chance you know the date?
Comment by PutinKhuylo1 on Jul 07, 2022 11:05am
It'll be a 10-Q and should come quickly after earnings release, which is assumed July 28-August 1.
Comment by lscfa on Jul 07, 2022 9:05am
Market thinks it's not much better than R+F deal......   Manufacturing and Supply Agreement with Rodan & Fields, LLC (“R&F”)   On September 13, 2019, the Company entered into a manufacturing and supply agreement, pursuant to which the Company shall manufacture, test, label, package, store and supply R&F a minimum of 10 kilograms per year of skin lightening ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities